Biopharmaceutical company Aegerion Pharmaceuticals has appointed Anne VanLent to its board of directors, effective as of April 26. VanLent will also chair the audit committee.

VanLent currently serves as president at AMV Advisors, a corporate strategy and financial consulting firm that she founded in 2008.

Previously, VanLent served as executive vice president and chief financial officer at former pharmaceutical company Barrier Therapeutics. Prior to that, she served as executive vice president of portfolio management at research and development firm Sarnoff Corporation.

Earlier in her career, VanLent served as senior vice president and CFO at former pharmaceutical company The Liposome Company.